lisofylline has been researched along with torbafylline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emeis, JJ; Tranquille, N | 1 |
| Alléra, A; Eisenhut, T; Endres, S; Gebert, U; Moeller, J; Schönharting, MM; Semmler, J | 1 |
2 other study(ies) available for lisofylline and torbafylline
| Article | Year |
|---|---|
The effect of pentoxifylline (Trental) and two analogues, BL 194 and HWA 448, on the release of plasminogen activators and von Willebrand factor in rats.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bradykinin; Endotoxins; Enzyme-Linked Immunosorbent Assay; Fibrinolysis; Hindlimb; In Vitro Techniques; Male; Pentoxifylline; Rats; Rats, Inbred Strains; Regional Blood Flow; Tissue Plasminogen Activator; von Willebrand Factor | 1991 |
Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Pentoxifylline; Theophylline; Tumor Necrosis Factor-alpha; Xanthines | 1993 |